Topics:

Gemzar Gets Treatment IND for Advanced Pancreatic Cancer

Gemzar Gets Treatment IND for Advanced Pancreatic Cancer

INDIANAPOLIS--Eli Lilly and Company has received FDA approval to provide gemcitabine (Gemzar) to advanced pancreatic cancer patients through a Treatment Investigational New Drug program.

The agent will be provided free of charge to patients who are not candidates for surgery and who meet certain medical eligibility criteria. Patients may have been previously untreated or have had one prior chemotherapy regimen. Physicians may call 1-800-621-7111 for more information about the Treatment IND.

 
Loading comments...
Please Wait 20 seconds or click here to close